|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2002-12-30
|
|
pubmed:abstractText |
Our previous studies have shown that oxidized low-density lipoprotein (ox-LDL) and angiotensin II (Ang II) influence each other's action in endothelial cells. This study was designed to examine the regulation by ox-LDL of the expression of angiotensin converting enzyme (ACE) gene in human coronary artery endothelial cells (HCAECs). In addition, we studied the effect of the HMG CoA reductase inhibitor simvastatin on this interaction.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA...,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/OLR1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Peptidyl-Dipeptidase A,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Oxidized LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Scavenger Receptors, Class E,
http://linkedlifedata.com/resource/pubmed/chemical/Simvastatin,
http://linkedlifedata.com/resource/pubmed/chemical/oxidized low density lipoprotein
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0008-6363
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
57
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
238-43
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12504834-Antibodies, Monoclonal,
pubmed-meshheading:12504834-Cells, Cultured,
pubmed-meshheading:12504834-Coronary Vessels,
pubmed-meshheading:12504834-Dose-Response Relationship, Drug,
pubmed-meshheading:12504834-Endothelium, Vascular,
pubmed-meshheading:12504834-Humans,
pubmed-meshheading:12504834-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:12504834-Lipoproteins, LDL,
pubmed-meshheading:12504834-Peptidyl-Dipeptidase A,
pubmed-meshheading:12504834-RNA, Messenger,
pubmed-meshheading:12504834-Receptors, LDL,
pubmed-meshheading:12504834-Receptors, Oxidized LDL,
pubmed-meshheading:12504834-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:12504834-Scavenger Receptors, Class E,
pubmed-meshheading:12504834-Simvastatin,
pubmed-meshheading:12504834-Time Factors
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Oxidized-LDL through LOX-1 increases the expression of angiotensin converting enzyme in human coronary artery endothelial cells.
|
|
pubmed:affiliation |
Department of Internal Medicine, University of Arkansas for Medical Sciences, Mail Slot 532, 4301 W Markham, Little Rock, AR 72205, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|
